July 7, 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved nogapendekin alfa inbakicept (Anktiva, ImmunityBio) for use in adults with carcinoma in situ (CIS) non-muscle-invasive bladder […]
July 7, 2025
TOPLINE: Patient-attributable delays exceeding 90 days in breast cancer care were associated with a more than threefold higher risk for 2-year mortality. Living alone emerged as […]
July 7, 2025
TOPLINE: Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have comparable overall survival and […]
July 7, 2025
Despite concerns about cognitive decline after cancer treatment, most breast cancer survivors show no increased risk of developing Alzheimer’s disease, and some may have a slightly […]
July 4, 2025
TOPLINE: An artificial intelligence (AI) model achieved a sensitivity of 91.8% in detecting pancreatic cancer on CT scans at diagnosis, with a 53.9% sensitivity for scans […]
July 4, 2025
While the use of radiation bridging therapy (BT) in chimeric antigen receptor (CAR) T-cell therapy for blood cancer is expanding, plenty of unanswered questions remain on […]
July 4, 2025
Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient’s body, body parts, […]
July 3, 2025
The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor […]
July 2, 2025
The FDA has granted accelerated approval to linvoseltamab (Lynozyfic, Regeneron) for relapsed or refractory multiple myeloma (MM) after at least four prior lines of therapy, including […]